Clinical implications of benign hematogone-rich lymphoid proliferations

Level of expression of CD20 in chronic lymphocytic leukemia and non-Hodgkin’s lymphoma

CD40L in CLL pathogensis

CD38 gene polymorphisms and susceptibility to B-cell lymphocytic leukemia

Implication of 6q aberration in non hodgkin lymphoma

Expression of fibromodulin gene as a tumor associated antigen in B-cell chronic lymphocytic leukemia

The role of cyclin dependent kinase inhibitor p27 in chronic lymphocytic leukemia

Chemokines and chemokine receptors in haematological disorders

Evaluation of telomerase activity in lymphoproliferative disorders

Molecular detection of 13q deletion in chronic lymphocytic leukemia